Articles tagged with Leukodystrophy
A new study describes a gene therapy strategy that uses the brain's glymphatic transport system to distribute engineered viral vectors throughout the brain. This approach enables preferential targeting of human glial cells while minimizing exposure to other cell types and organs, addressing two major challenges in neurological medicine.
Davis Joseph's groundbreaking discovery identifies a common master switch that can cure multiple brain-related diseases with a single method. The unified theory establishes that regulating axon-based 4E-BP2 protein deamidation can control disease progression.
Scientists have long believed that cells respond to stress in a linear chain of events, but a new study reveals a more complex 'split-integrated stress response' that can be fine-tuned depending on the type and intensity of stress. This flexibility could lead to new targets for treating cancer and neurodegenerative diseases.
Researchers compared urine NAA levels in patients with mild and typical Canavan disease, finding lower levels in those with the milder form. This discovery has potential for a rapid and cost-effective way to screen for CD incidence and severity.
A team of neuroscientists has discovered that oligodendrocytes, myelin-forming cells, accelerate glucose consumption to deliver energy-rich molecules to rapidly firing axons. This communication is mediated by potassium signals and maintains axonal health.
A mutation in the TMEM163 zinc transporter gene has been definitively linked to hypomyelinating leukodystrophy, a rare and often fatal neurological disorder. The study's findings provide new insights into the role of zinc in normal brain development, injury, and disease.
Researchers at the University of Sheffield have discovered a link between defective immune cells and rare childhood brain disorders, such as leukodystrophies. These diseases cause severe physical and mental disabilities in children, with limited treatment options available.
Researchers used human induced pluripotent stem cells and CRISPR/Cas9 gene editing to model chemical changes in GFAP protein associated with Alexander disease. The study reveals differences in GFAP modifications depending on symptom onset time, allowing for new drug development opportunities.
Researchers at Wayne State University are exploring leukodystrophies and genetic Leukoencephalopathies, rare disorders affecting the central nervous system. They will use a zebrafish mutant line of Vacuolar Protein Sorting 11 to better understand the progression and model for a disease causing progressive vision loss.
A new crucial gene, POLR1C, has been identified as the cause of nearly 10% of cases with 4H leukodystrophy, a common form of the disease. This discovery sheds light on the molecular mechanism behind the disease and may lead to new diagnostic tools and therapeutic options.
A Montreal-led international team identified the mutated gene POLR3A as responsible for three forms of leukodystrophies, a group of childhood-onset neurodegenerative disorders. The findings provide crucial insights into diagnostic tests and genetic counseling, as well as potential therapeutic strategies to replace defective genes.